Michael J. Kramer

Michael J. Kramer

  • • 20 years of investing and industry experience
  • • 10 years as a buy side equity trader
  • • Founder of Mott Capital Management in 2014


Michael Kramer is the Founder of Mott Capital Management. His unique investment philosophy centers on seeking investment opportunities that are influenced by everyday life activities, and by observing new trends and products that are popular or are trending towards popularity. Additionally, he devotes a significant part of his research to global macroeconomics and central bank policies impacting financial markets.

Kramer runs the Mott Capital Management actively managed long-only Thematic Growth Portfolio, which holds these stocks: AAPL, ACAD, ALKS, CELG, DEO, DIS, GOOGL, MA, MO, NFLX, NXPI, RTN, SWKS TSLA, UL, V, VOD and VZ.

Kramer began his career in high-risk trading environments, trading both US and international equities. His trading skills coupled with his comprehensive, financial analysis of public companies, have given him a unique perspective on investing, which stands out from analysts who simply look at top-line numbers. In addition to fundamental analysis, Kramer also incorporates technical and options market analysis into his research.

Kramer is a fundamental writer for Investopedia.com, analyzing stocks and market news that is helpful for everyday investors to make short and long-term investment decisions.


Michael received his Master's Degree in Investment Management from Pace University.

Quote from Michael

"I like to help people become smarter and better investors."

Investopedia and Dotdash

Investopedia helps you understand complex financial concepts, learn and improve your investing skills, and learn how to manage your money. Whether you’re in a classroom, a boardroom or your living room, our editors and network of financial advisors and experts have answered your questions and proudly earned your trust since 1999. Investopedia is part of Dotdash, a collection of some of the web’s largest and most trusted digital media brands.

  1. Stocks

    The Contrarian: Jefferies Oversells Under Armour

    Jefferies upgraded UA and raised its price target to $27, but we do wonder why.
  2. Stocks

    Movie Theater Stocks Move Up Ahead of Weekend (AMC, RGC)

    AMC and RGC are moving up ahead of potential hot weekend at the box office.
  3. Stocks

    Broadcom Up Following Micron Lead (AVGO, NVDA)

    AVGO shares are moving higher, after MU reported strong quarterly results.
  4. Stocks

    Stalling Healthcare Reform May Be Holding Up the Rally

    It appears that partisan gridlock over healthcare reform may be helping to derail the rally.
  5. Stocks

    The Market Cries Wolf on Disney's ESPN

    Investors and analysts are making a big deal about ESPN for no good reason.
  6. Stocks

    Allergan Acts Well In Poor Sector (AGN)

    AGN shares have held up well in the last couple of days despite a weak sector.
  7. Stocks

    Looking Into Nike Results (NKE)

    Nike shares fell over 6% after the company reported third-quarter earnings of 68 cents a share.
  8. Stocks

    Nvidia Not Out Of The Woods Yet (NVDA)

    NVDA still hasn't crossed $110 yet.
  9. Stocks

    Barclays Downgrades Sirius XM Holdings (SIRI)

    Barclays downgraded SIRI to Equalweight from Overweight.
  10. Stocks

    The Contrarian: BTIG Goes All In on Facebook (FB)

    BTIG has raised Facebook to a Buy from Neutral and put a $175 price target on the stock, but these targets seem challenging, ...
  11. Stocks

    Allergan Sets Up Nicely For Near-Term Move (AGN)

    Allergan shares are setting up for nicely for a possible move higher.
  12. Stocks

    What The Market Thinks About The TSLA Secondary (TSLA)

    Trading in shares of TSLA suggests the market liked the company's recent secondary offering.
  13. Stocks

    Movie Theaters Stocks Up On Strong Weekend (IMAX, AMC)

    Movie theater stocks jumped following a strong weekend at the box office.
  14. Stocks

    Did Nvidia Just Break Out? (NVDA)

    NVDA shares are the verge of a potential short-term breakout.
  15. Stocks

    The Contrarian: Analyst Crapshoot on Valeant (VRX)

    Stifel has reiterated its buy rating on shares of Valeant and a $45 price target, but all we have are questions.